Published :
Tables : 62
Figures : 52
Category : Healthcare
No. of Pages : 230
Report Code : HC-U3330
Pneumococcal Testing Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027. There has been a substantial rise in the number of pneumococcal testing across the world with the current COVID-19 pandemic. Rising emphasis on molecular diagnostics for detecting respiratory pathogens has resulted in the pneumococcal testing market growth to a substantial level. Furthermore, this testing has gained clinical importance with respect to the ability of demonstrating high analytical specificity and sensitivity along with the capability of processing multiple respiratory specimens. The point of care testing is generally preferred as the conventional testing technique. This can be credited to the increased necessity to offer real-time results that aid the physicians to make correct decisions in the disease treatment. Furthermore, these tests are used for medical care has shifted focus on early detection, prevention and managing chronic conditions. Market Segmentation: By Method • Immunodiagnostics • Molecular Diagnostics • Point of Care Testing By Technology • Enzyme Linked Immunosorbent Assay • Immunofluorescence • Western Blot • Polymerase Chain Reaction • Immunohistochemistry • Others By End User • Hospitals • Homecare • Diagnostic Laboratories • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is categorised into method, technology, end user and region. The method segment is fragmented into immunodiagnostics, molecular diagnostics and point of care diagnostics. The point of care testing market held the largest pneumococcal testing market share during the forecast period as this method can test multiple samples at once which provides efficient workflow for healthcare organizations. The technology segment is bifurcated into enzyme linked immunohistochemistry, immunofluorescence, polymerase chain reaction, western block and others. The end user segment is classified into hospital, diagnostic laboratories, homecare and others. The hospital segment is anticipated to lead the market owing to a rise in the number of patients diagnosed with pneumococcal symptoms with the ongoing COVID-19 pandemic. Regional Analysis: The North America region is predicted to dominate the market during the forecast period owing to a strong presence of key market players in the region, growing investments for research and development in pneumococcal testing methodologies. The Asia Pacific region, on the other hand, is expected to lead the market owing to increased demand for these tests with the rising geriatric population in countries like Japan, China. Competitive Landscape: Some of the prominent players of the market are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, Quidel. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global pneumococcal testing market by method, by technology, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
There has been a substantial rise in the number of pneumococcal testing across the world with the current COVID-19 pandemic. Rising emphasis on molecular diagnostics for detecting respiratory pathogens has resulted in the pneumococcal testing market growth to a substantial level. Furthermore, this testing has gained clinical importance with respect to the ability of demonstrating high analytical specificity and sensitivity along with the capability of processing multiple respiratory specimens. The point of care testing is generally preferred as the conventional testing technique. This can be credited to the increased necessity to offer real-time results that aid the physicians to make correct decisions in the disease treatment. Furthermore, these tests are used for medical care has shifted focus on early detection, prevention and managing chronic conditions.
Market Segmentation:
By Method • Immunodiagnostics • Molecular Diagnostics • Point of Care Testing By Technology • Enzyme Linked Immunosorbent Assay • Immunofluorescence • Western Blot • Polymerase Chain Reaction • Immunohistochemistry • Others By End User • Hospitals • Homecare • Diagnostic Laboratories • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is categorised into method, technology, end user and region. The method segment is fragmented into immunodiagnostics, molecular diagnostics and point of care diagnostics. The point of care testing market held the largest pneumococcal testing market share during the forecast period as this method can test multiple samples at once which provides efficient workflow for healthcare organizations. The technology segment is bifurcated into enzyme linked immunohistochemistry, immunofluorescence, polymerase chain reaction, western block and others. The end user segment is classified into hospital, diagnostic laboratories, homecare and others. The hospital segment is anticipated to lead the market owing to a rise in the number of patients diagnosed with pneumococcal symptoms with the ongoing COVID-19 pandemic.
Regional Analysis:
The North America region is predicted to dominate the market during the forecast period owing to a strong presence of key market players in the region, growing investments for research and development in pneumococcal testing methodologies. The Asia Pacific region, on the other hand, is expected to lead the market owing to increased demand for these tests with the rising geriatric population in countries like Japan, China.
Competitive Landscape:
Some of the prominent players of the market are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, Quidel.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global pneumococcal testing market by method, by technology, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Pneumococcal Testing Market, By Method Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Immunodiagnostics 7.2 Molecular Diagnostics 7.3 Point of Care Testing 8. Pneumococcal Testing Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Enzyme Linked Immunosorbent Assay 8.2 Immunofluorescence 8.3 Western Blot 8.4 Polymerase Chain Reaction 8.5 Immunohistochemistry 8.6 Others 9. Pneumococcal Testing Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Hospitals 9.2 Homecare 9.3 Diagnostic Laboratories 9.4 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4 Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Uruguay 11.3.3 Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 Thermo Fisher Scientific Inc. 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Abbott Laboratories 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 F-Hoffmann la Roche Ltd. 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 Hologic Inc. 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 bioMerieux 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Becton Dickenson and Company 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Bio-Rad Laboratories Inc. 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 Meridian Biosciences 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9 Quest Diagnostics 15.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10 Quidel 15.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16 Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics